TELO · Telomir Pharmaceuticals Inc
United States · RS rating 19 · As of 2026-11-03
| Price | 0.91 USD |
|---|---|
| 1-day change | -0.6% |
| RS rating (overall / 1M / 3M / 12M) | 19 / 17 / 28 / 25 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 19 / 7 / 33 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +39.3% |
| Market cap (USD) | $47.4M |